digital currency wallet app- Top Block

News before the US stock market, ① The three major stock index futures of the US stock market rose together, and crude oil futures rose by more than 1%. Today, the US import/export price index for November was announced. ② As of press time, Dow futures rose 0.26%, S&P 500 futures rose 0.36%, and Nasdaq futures rose 0.73%. (3) Germany's DAX index rose by 0.47%, Britain's FTSE 100 index rose by 0.15%, France's CAC40 index rose by 0.38% and Europe's Stoxx 50 index rose by 0.46%. ④WTI crude oil rose 1.19% to 70.85 USD/barrel. Brent crude oil rose 1.16% to $74.26/barrel. ⑤ Societe Generale warned that the recession index of 75-year winning streak indicates that the United States may be in recession. Behind the record high of American stock market, there is a trend that worries Wall Street strategists: fewer and fewer stocks support the stock market. ⑦ Xpeng Motors fell more than 3.5% before trading and was downgraded to "sell" by UBS. ⑧ Broadcom rose about 14% before the market, and the company's Q4 profit exceeded expectations. Pet-name ruby ZTO Express rose more than 1% before trading, and the average monthly express business volume in China reached 14 billion pieces.Market News: US Secretary of State Blinken met with Iraqi Prime Minister in Baghdad to discuss the Syrian issue.France's new Prime Minister Bayrou: I know my task is arduous, and we need to unite the people. Everyone knows that this road will be long.

BYD Lian Yubo: It is estimated that BYD will sell 4.25 million vehicles in the whole year. On December 13th, BYD's chief scientist Lian Yubo said: "Up to now, BYD has sold more than 10 million new energy vehicles. By the end of this month, we can probably achieve the annual sales of 4.25 million vehicles. " He also mentioned: "There are still some challenges in industrial development. For example, the overall anti-risk ability of our industrial chain needs to be improved, and there are still breakthroughs in chips, operating technologies, industrial software and nuclear materials. We still need to strengthen research and achieve complete autonomy and controllability."Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Hikvision: The controlling shareholder has obtained a commitment letter for a special loan of 120 million yuan to increase its holdings. Hikvision announced that the company recently received a notice from the controlling shareholder, CLP Hikvision, that CLP Hikvision has obtained a commitment letter for a special loan to increase its holdings issued by China Industrial and Commercial Bank of China. Hangzhou Branch of Industrial and Commercial Bank of China will provide a loan fund of no more than 120 million yuan for CLP Hikvision Group to increase its shareholding in Hikvision by centralized bidding, and the loan period will not exceed 3 years.

Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Market News: Director of South Korea's National Police Agency will be arrested.Russian Ministry of Defence: Russian armed forces occupied seven settlements in one week.